AVBP

AVBP Total Current Liabilities

$27.84MQuarterly · USD

Period ending:

AVBP FY Current LiabilitiesUSD
AVBP FY Current Liabilities2021-12-31: $1.82M2022-12-31: $8.36M2023-12-31: $11.62M2024-12-31: $17.27M2025-12-31: $25.95M$25.95M$0.00
2021-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVBP total current liabilities history

Liabilities due within one year. The available annual fiscal periods series contains 5 observations from Dec 31, 2021 to Dec 31, 2025.

Arrivent Biopharma Inc Total Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Current Liabilities (USD)
25,945,000
17,274,000
11,624,000
8,360,000
1,818,000

Compare total current liabilities

All AVBP financial metrics · AVBP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.